Failure of senescent cells to phosphorylate the RB protein.

Abstract:

:The product of the RB susceptibility gene has been shown to be differentially phosphorylated during the cell cycle, suggesting a role in the regulation of cell cycle progression. We examined the expression and phosphorylation status of the RB protein in senescent Syrian hamster embryo cells. Both phosphorylated and unphosphorylated forms of the RB protein were observed in cells at early passages; however, only unphosphorylated RB protein was found in senescent cells. When nonsenescent cells at low population doubling levels were made quiescent by reducing the serum concentration of the media, the RB protein in these cells was mostly in the unphosphorylated form. When stimulated with serum, phosphorylation of the RB protein occurred between 10-20 h after stimulation, which corresponded with the induction of DNA synthesis. Senescent cells, in contrast, did not show any phosphorylation of the RB protein in response to serum. In addition, cell lines that had escaped cellular senescence at various stages of neoplastic progression were examined; all 25 cell lines examined expressed RB protein, which was phosphorylated normally. These results suggest that the RB protein plays a role in cellular senescence with phosphorylation status determining this role. Factors controlling this phosphorylation are potential key factors in controlling cellular life span in culture.

journal_name

Oncogene

journal_title

Oncogene

authors

Futreal PA,Barrett JC

subject

Has Abstract

pub_date

1991-07-01 00:00:00

pages

1109-13

issue

7

eissn

0950-9232

issn

1476-5594

journal_volume

6

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • The role of immunoglobulin kappa elements in c-myc activation.

    abstract::Burkitt's lymphoma cells are characterized by chromosomal translocations involving the proto-oncogene c-myc on chromosome 8 and one of the immunoglobulin gene loci on chromosome 2, 14 or 22. The translocated c-myc allele is transcriptionally activated, shows a preferential usage of promoter P1 over P2 (promoter shift)...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Hörtnagel K,Mautner J,Strobl LJ,Wolf DA,Christoph B,Geltinger C,Polack A

    更新日期:1995-04-06 00:00:00

  • Isolation of HELAD1, a novel human helicase gene up-regulated in colorectal carcinomas.

    abstract::To investigate the mechanisms of colorectal carcinogenesis, we searched for genes regulated by adenomatous polyposis coli gene product (APC) and identified a novel gene, termed HELAD1 (helicase, APC down-regulated 1). A recombinant polypeptide representing the ATPases associated with cellular activities (AAA) domain o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205751

    authors: Ishiguro H,Shimokawa T,Tsunoda T,Tanaka T,Fujii Y,Nakamura Y,Furukawa Y

    更新日期:2002-09-12 00:00:00

  • Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene.

    abstract::The onset of human lung cancer occurs through sequential mutations in oncogenes and tumor suppressor genes. Mutations in K-Ras play a prominent role in human non-small cell lung cancer. We have developed a mouse lung tumor model in which K-Ras can be sporadically activated through Cre-lox mediated somatic recombinatio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204837

    authors: Meuwissen R,Linn SC,van der Valk M,Mooi WJ,Berns A

    更新日期:2001-10-04 00:00:00

  • Essential roles of ERK-mediated phosphorylation of vinexin in cell spreading, migration and anchorage-independent growth.

    abstract::Vinexin is an adaptor protein supposed to play pivotal roles in various cellular events such as cell adhesion, cytoskeletal organization, signaling and gene expression. Despite the possible importance, physiological functions and regulatory mechanisms of vinexin are largely unknown. In addition, although vinexin was r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210512

    authors: Mizutani K,Ito H,Iwamoto I,Morishita R,Deguchi T,Nozawa Y,Asano T,Nagata KI

    更新日期:2007-11-01 00:00:00

  • Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol.

    abstract::Radicicol, a macrocyclic anti-fungal antibiotic, has the ability to suppress transformation by diverse oncogenes such as Src, Ras and Mos. Despite this useful property, the mechanism by which radicicol exerts its anti-transformation effects is currently unknown. To understand the transformation-suppressing effects of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201790

    authors: Sharma SV,Agatsuma T,Nakano H

    更新日期:1998-05-01 00:00:00

  • Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.

    abstract::Ataxia-Telangiectasia (A-T) is an autosomal recessive human disease characterized by genetic instability, radiosensitivity, immunodeficiency and cancer predisposition, because of mutation in both alleles of the ATM (ataxia-telangiectasia mutated) gene. The role of Atm heterozygosity in cancer susceptibility is controv...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.280

    authors: Mao JH,Wu D,DelRosario R,Castellanos A,Balmain A,Perez-Losada J

    更新日期:2008-11-20 00:00:00

  • KATs in cancer: functions and therapies.

    abstract::Post-translational acetylation of lysines is most extensively studied in histones, but this modification is also found in many other proteins and is implicated in a wide range of biological processes in both the cell nucleus and the cytoplasm. Like phosphorylation, acetylation patterns and levels are often altered in ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2014.453

    authors: Farria A,Li W,Dent SY

    更新日期:2015-09-17 00:00:00

  • Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo.

    abstract::Lymphoid cells and small intestinal epithelial (SIE) cells are among the most radiosensitive in the body. The factors that account for the differential sensitivity to gamma-radiation among different tissue-types remain poorly understood, but can only partly be explained by differences in rates of cell proliferation. H...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kitada S,Krajewski S,Miyashita T,Krajewska M,Reed JC

    更新日期:1996-01-04 00:00:00

  • PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis.

    abstract::Poly(ADP-ribose) polymerase 1 (PARP1) interacts genetically with the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) to suppress early-onset T-lineage lymphomas in the mouse, but the underlying mechanisms have remained unknown. To address this question, we analyzed a series of lymphomas arising in PARP1(-/-)...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.199

    authors: Rybanska I,Ishaq O,Chou J,Prakash M,Bakhsheshian J,Huso DL,Franco S

    更新日期:2013-04-04 00:00:00

  • Characterization of changes in gene expression associated with malignant transformation by the NF-kappaB family member, v-Rel.

    abstract::In this study, alterations in gene expression patterns have been examined in v-Rel-transformed avian bone marrow cells. Using a conditional v-Rel estrogen receptor chimera (v-RelER) which transforms cells in an estrogen-dependent manner, we constructed subtraction cDNA libraries from v-RelER-transformed bone marrow ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201334

    authors: Petrenko O,Ischenko I,Enrietto PJ

    更新日期:1997-10-02 00:00:00

  • Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition.

    abstract::Reexpression of hypermethylated tumor suppressor genes using DNA methyltransferase (DNMT) and histone deacetylase inhibitors occurs by a mechanism whereby promoter demethylation is the dominant event. In support of this model, we found in acute myeloid leukemia cells with hypermethylated p15INK4B and E-cadherin promot...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.361

    authors: Lakshmikuttyamma A,Scott SA,DeCoteau JF,Geyer CR

    更新日期:2010-01-28 00:00:00

  • Microsatellite instability in prostate cancer.

    abstract::Assessment of the genetic instability of a microsatellite has indicated a new mechanism in human carcinogenesis. Examination was made to determine whether microsatellite instability is associated with the onset of prostate cancer. Twenty-nine DNA samples from 24 primary prostate cancer, two metastatic lymph-node and t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Uchida T,Wada C,Wang C,Ishida H,Egawa S,Yokoyama E,Ohtani H,Koshiba K

    更新日期:1995-03-02 00:00:00

  • DNA methylation and gene silencing in cancer: which is the guilty party?

    abstract::The DNA methylation pattern of a cell is exquisitely controlled during early development resulting in distinct methylation patterns. The tight control of DNA methylation is released in the cancer cell characterized by a reversal of methylation states. CpG island associated genes, in particular tumour suppressor or rel...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1205598

    authors: Clark SJ,Melki J

    更新日期:2002-08-12 00:00:00

  • Characterization of VIK-1: a new Vav-interacting Kruppel-like protein.

    abstract::Binding partners of the Src homology domains of Vav-1 were characterized by a two-hybrid screening of a Jurkat cell cDNA library. One of the isolated clones encoded a new protein named VIK that belongs to the Kruppel-like zinc-finger gene family. Genome mapping showed that a single gene positioned at chromosome 7q22.1...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208043

    authors: Houlard M,Romero-Portillo F,Germani A,Depaux A,Regnier-Ricard F,Gisselbrecht S,Varin-Blank N

    更新日期:2005-01-06 00:00:00

  • Detection of PTEN nonsense mutation and psiPTEN expression in central nervous system high-grade astrocytic tumors by a yeast-based stop codon assay.

    abstract::We have developed a new yeast-based assay for the detection of PTEN nonsense mutation, and applied it to a total of 42 astrocytic tumors. The assay utilizes homologous recombination of PCR-amplified PTEN cDNA samples to a yeast vector which expresses an in-frame PTEN::ADE2 chimera protein. An allele of nonsense mutati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203795

    authors: Zhang CL,Tada M,Kobayashi H,Nozaki M,Moriuchi T,Abe H

    更新日期:2000-09-07 00:00:00

  • Suppression of v-Src transformation in primary rat embryo fibroblasts.

    abstract::To understand the mechanism for resistance of primary cultures of rat embryo fibroblasts (REFs) to oncogene-induced transformation, we studied the transforming ability of a recombinant retrovirus, ZSV, containing v-src and neo genes in REFs and in the rat cell line F2408. The susceptibility of REFs to p60v-src transfo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Inoue H,Tavoloni N,Hanafusa H

    更新日期:1995-07-20 00:00:00

  • Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism.

    abstract::Hec1 (highly expressed in cancer 1) or Nek2 (NIMA-related kinase 2) is often overexpressed in cancers with poor prognosis. Both are critical mitotic regulators, and phosphorylation of Hec1 S165 by Nek2 is required for proper chromosome segregation. Therefore, inactivation of Hec1 and Nek2 by targeting their interactio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.67

    authors: Hu CM,Zhu J,Guo XE,Chen W,Qiu XL,Ngo B,Chien R,Wang YV,Tsai CY,Wu G,Kim Y,Lopez R,Chamberlin AR,Lee EY,Lee WH

    更新日期:2015-03-05 00:00:00

  • Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer.

    abstract::Intrinsic and acquired resistance to anti-EGFR antibody therapy, frequently mediated by a mutant or amplified KRAS oncogene, is a significant challenge in the treatment of colorectal cancer (CRC). However, the mechanism of KRAS-mediated therapeutic resistance is not well understood. In this study, we demonstrate that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0289-x

    authors: Knickelbein K,Tong J,Chen D,Wang YJ,Misale S,Bardelli A,Yu J,Zhang L

    更新日期:2018-08-01 00:00:00

  • Identification of RASSF8 as a candidate lung tumor suppressor gene.

    abstract::The RASSF8 gene, which maps close to the KRAS2 gene, contains a RAS-associated domain and encodes a protein that is evolutionarily conserved from fish to humans. Analysis of the RASSF8 transcript revealed a complex expression pattern of 5'-UTR mRNA isoforms in normal lung and in lung adenocarcinomas (ADCAs), with no a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209422

    authors: Falvella FS,Manenti G,Spinola M,Pignatiello C,Conti B,Pastorino U,Dragani TA

    更新日期:2006-06-29 00:00:00

  • Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.

    abstract::The discovery of constitutive nuclear factor-κB (NF-κB) activation in Hodgkin's lymphoma tumor cells almost two decades ago was one of the first reports that directly connected deregulated NF-κB signaling to human cancer. Subsequent studies demonstrated that enhanced NF-κB signaling is a common hallmark of many lympho...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.565

    authors: Nagel D,Vincendeau M,Eitelhuber AC,Krappmann D

    更新日期:2014-12-11 00:00:00

  • Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma.

    abstract::H1 histamine receptor (H1HR) belongs to the family of rhodopsin-like G-protein-coupled receptors. Recent studies have shown that H1HR expression is increased in several types of cancer. However, its functional roles in tumor progression remain largely unknown, especially in hepatocellular carcinoma (HCC). We found tha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-1093-y

    authors: Zhao J,Hou Y,Yin C,Hu J,Gao T,Huang X,Zhang X,Xing J,An J,Wan S,Li J

    更新日期:2020-02-01 00:00:00

  • Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1.

    abstract::Fanconi anemia is a hereditary cancer susceptibility disorder characterized at the cellular level by spontaneous chromosomal instability and specific hypersensitivity to DNA cross-linking agents such as mitomycin C. This phenotype suggests a possible role for the Fanconi anemia proteins in the repair of DNA lesions in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205656

    authors: Godthelp BC,Artwert F,Joenje H,Zdzienicka MZ

    更新日期:2002-07-25 00:00:00

  • Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression.

    abstract::Alu sequences are the most abundant short interspersed repeated elements in the human genome. Here we show that in a cell culture model of colorectal cancer (CRC) progression, we observe accumulation of Alu RNA that is associated with reduced DICER1 levels. Alu RNA induces epithelial-to-mesenchymal transition (EMT) by...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.369

    authors: Di Ruocco F,Basso V,Rivoire M,Mehlen P,Ambati J,De Falco S,Tarallo V

    更新日期:2018-02-01 00:00:00

  • Quantitative analysis of Grb2-Sos1 interaction: the N-terminal SH3 domain of Grb2 mediates affinity.

    abstract::Grb2 is an adaptor protein that links receptor and cytoplasmic tyrosine kinases to the Ras signalling pathway by binding the Ras-specific guanine nucleotide exchange factor, Sos1, through its SH3 domains. The Grb2-SH3 domain binding has been localized to the carboxy-terminal two hundred amino acids of Sos1 (Sos1-c). B...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sastry L,Lin W,Wong WT,Di Fiore PP,Scoppa CA,King CR

    更新日期:1995-09-21 00:00:00

  • The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein.

    abstract::The Epstein-Barr virus latency-associated membrane protein LMP2A has been shown to activate the survival kinase Akt in epithelial and B cells in a phosphoinositide 3-kinase-dependent fashion. In this study, we demonstrate that the signalling scaffold Shb associates through SH2 and PTB domain interactions with phosphor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210298

    authors: Matskova LV,Helmstetter C,Ingham RJ,Gish G,Lindholm CK,Ernberg I,Pawson T,Winberg G

    更新日期:2007-07-26 00:00:00

  • Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays.

    abstract::Identifying novel and known genes that are differentially expressed in breast cancer has important implications in understanding the biology of breast tumorigenesis and developing new diagnostic and therapeutic agents. In this study we have combined two powerful technologies, PCR-based cDNA subtraction and cDNA microa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205278

    authors: Jiang Y,Harlocker SL,Molesh DA,Dillon DC,Stolk JA,Houghton RL,Repasky EA,Badaro R,Reed SG,Xu J

    更新日期:2002-03-28 00:00:00

  • MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells.

    abstract::Over 70% of human breast cancers are estrogen receptor-positive (ER+), most of which express MYB. In these and other cell types, the MYB transcription factor regulates the expression of many genes involved in cell proliferation, differentiation, tumorigenesis, and apoptosis. So far, no clear link has been established ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0789-3

    authors: Yang RM,Nanayakkara D,Kalimutho M,Mitra P,Khanna KK,Dray E,Gonda TJ

    更新日期:2019-06-01 00:00:00

  • The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma.

    abstract::The phosphatidylinositol 3'-kinase (PI3K) pathway is dysregulated in multiple myeloma (MM); we therefore tested a highly selective class I PI3K inhibitor, GDC-0941, for anti-myeloma activity. Functional and mechanistic studies were first performed in MM cell lines, then extended to primary MM patient samples cultured ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.594

    authors: Munugalavadla V,Mariathasan S,Slaga D,Du C,Berry L,Del Rosario G,Yan Y,Boe M,Sun L,Friedman LS,Chesi M,Leif Bergsagel P,Ebens A

    更新日期:2014-01-16 00:00:00

  • E2F regulates DDB2: consequences for DNA repair in Rb-deficient cells.

    abstract::DDB2, a gene mutated in XPE patients, is involved in global genomic repair especially the repair of cyclobutane pyrimidine dimers (CPDs), and is regulated by p53 in human cells. We show that DDB2 is expressed in mouse tissues and demonstrate, using primary mouse epithelial cells, that mouse DDB2 is regulated by E2F tr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210151

    authors: Prost S,Lu P,Caldwell H,Harrison D

    更新日期:2007-05-24 00:00:00

  • Biochemical and mutagenic analysis of the melanoma tumor suppressor gene product/p16.

    abstract::P16 was originally discovered by its ability to interact with CDK4 and to specifically inhibit the catalytic activity of the CDK4/D1 kinase. Increased attention has focused on the p16 gene because of its location on chromosome 9p21, a region involved in chromosomal rearrangements in a large number of tumor types. The ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wick ST,Dubay MM,Imanil I,Brizuela L

    更新日期:1995-11-16 00:00:00